|
MRE11
(HGNC:7230)
|
breast cancer
(MONDO_0007254)
|
Disputed
|
|
|
MRE11
(HGNC:7230)
|
prostate cancer
(MONDO_0008315)
|
Limited
|
|
|
MPZ
(HGNC:7225)
|
Charcot-Marie-Tooth disease
(MONDO_0015626)
|
Definitive
|
|
|
MRAS
(HGNC:7227)
|
Noonan syndrome
(MONDO_0018997)
|
Strong
|
|
|
MPZ
(HGNC:7225)
|
Charcot-Marie-Tooth disease type 3
(MONDO_0007790)
|
Strong
|
|
|
MPZ
(HGNC:7225)
|
Charcot-Marie-Tooth disease type 2J
(MONDO_0011903)
|
Moderate
|
|
|
MPZ
(HGNC:7225)
|
Charcot-Marie-Tooth disease type 1B
(MONDO_0007307)
|
Definitive
|
|
|
MPV17
(HGNC:7224)
|
mitochondrial disease
(MONDO_0044970)
|
Strong
|
|
|
MPV17
(HGNC:7224)
|
mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
(MONDO_0009747)
|
Strong
|
|
|
MPV17
(HGNC:7224)
|
Charcot-Marie-Tooth disease, axonal, type 2EE
(MONDO_0032728)
|
Moderate
|
|
|
MPST
(HGNC:7223)
|
encephalopathy due to beta-mercaptolactate-cysteine disulfiduria
(MONDO_0009585)
|
Limited
|
|
|
MPL
(HGNC:7217)
|
familial thrombocytosis
(MONDO_0019111)
|
Strong
|
|
|
ARSL
(HGNC:719)
|
X-linked chondrodysplasia punctata 1
(MONDO_0010555)
|
Strong
|
|
|
MOCS2
(HGNC:7193)
|
sulfite oxidase deficiency due to molybdenum cofactor deficiency type B
(MONDO_0009644)
|
Strong
|
|
|
MOCS1
(HGNC:7190)
|
sulfite oxidase deficiency due to molybdenum cofactor deficiency type A
(MONDO_0009643)
|
Strong
|
|
|
MN1
(HGNC:7180)
|
CEBALID syndrome
(MONDO_0032908)
|
Strong
|
|
|
ALDH6A1
(HGNC:7179)
|
methylmalonate semialdehyde dehydrogenase deficiency
(MONDO_0013579)
|
Moderate
|
|
|
MMP9
(HGNC:7176)
|
metaphyseal anadysplasia 2
(MONDO_0013113)
|
Limited
|
|
|
MMP2
(HGNC:7166)
|
multicentric osteolysis-nodulosis-arthropathy spectrum
(MONDO_0018298)
|
Strong
|
|
|
MMP14
(HGNC:7160)
|
multicentric osteolysis-nodulosis-arthropathy spectrum
(MONDO_0018298)
|
Moderate
|
|